BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38309289)

  • 1. Integrated single-cell and bulk characterization of branched chain amino acid metabolism-related key gene BCAT1 and association with prognosis and immunogenicity of clear cell renal cell carcinoma.
    Zheng J; Liu Y; Wang J; Shi J; Li L; Jiang X; Tao L
    Aging (Albany NY); 2024 Feb; 16(3):2715-2735. PubMed ID: 38309289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma.
    Wei K; Zhang X; Yang D
    PeerJ; 2023; 11():e16643. PubMed ID: 38130918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMP1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma.
    Li Q; Wei K; Zhang X; Lv Y; Li M; Zhou C; Su S; Hou D; Hou J
    Aging (Albany NY); 2023 Sep; 15(17):8908-8929. PubMed ID: 37688768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma.
    Zhang X; Zhang M; Song L; Wang S; Wei X; Shao W; Song N
    Sci Rep; 2023 Nov; 13(1):20266. PubMed ID: 37985807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
    Chen Y; He J; Jin T; Zhang Y; Ou Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an immune-related eRNA prognostic signature for clear cell renal cell carcinoma.
    Lv Y; Niu L; Li Q; Shao W; Yan X; Li Y; Yue Y; Chen H
    Aging (Albany NY); 2024 Jan; 16(3):2232-2248. PubMed ID: 38289619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma.
    Tan D; Miao D; Zhao C; Shi J; Lv Q; Xiong Z; Yang H; Zhang X
    BMC Cancer; 2023 Mar; 23(1):264. PubMed ID: 36949462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
    He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Crotonylation Metabolism Signature Predicting Overall Survival for Clear Cell Renal Cell Carcinoma.
    Zheng J; Liu Y; Wei K; Shi J; Li L; Jiang X; Tao L
    Int J Clin Pract; 2023; 2023():5558034. PubMed ID: 38058677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a polyamine gene expression score for predicting prognosis and treatment response in clear cell renal cell carcinoma.
    Chen M; Nie Z; Huang D; Gao Y; Cao H; Zheng L; Zhang S
    Front Immunol; 2022; 13():1048204. PubMed ID: 36505496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A promising natural killer cell-based model and a nomogram for the prognostic prediction of clear-cell renal cell carcinoma.
    Yao Q; Zhang X; Wang Y; Wang C; Chen J; Chen D
    Eur J Med Res; 2024 Jan; 29(1):73. PubMed ID: 38268058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
    Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
    Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging the gap between clear cell renal cell carcinoma and cutaneous melanoma: the role of SCARB1 in dysregulated cholesterol metabolism.
    Song L; Wang S; Zhang X; Song N; Lu Y; Qin C
    Aging (Albany NY); 2023 Oct; 15(19):10370-10388. PubMed ID: 37801479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
    Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
    Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.
    Zhang L; Han J
    Biochem Biophys Res Commun; 2017 Apr; 486(2):224-231. PubMed ID: 28235484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Tumor Mutation Burden Related lncRNA Signature Identified Prognosis and Tumor Immune Microenvironment Features in Clear Cell Renal Cell Carcinoma.
    Lin L; Wu XH; Zhu JM; Chen SH; Chen YH; Lin F; Xue XY; Wei Y; Xu N; Zheng QS; Sun XL
    Comb Chem High Throughput Screen; 2023; 26(8):1503-1518. PubMed ID: 36165528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Arginine Methyltransferases Refine the Classification of Clear Cell Renal Cell Carcinoma with Distinct Prognosis and Tumor Microenvironment Characteristics.
    Ye S; Tian X; Anwaier A; Wei S; Liu W; Su J; Zhu S; Dai B; Gu J; Qu Y; Xu W; Zhang H; Ye D
    Int J Biol Sci; 2023; 19(14):4552-4570. PubMed ID: 37781030
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma.
    Lin H; Fu L; Li P; Zhu J; Xu Q; Wang Y; Mumin MA; Zhou X; Chen Y; Shu G; Yao G; Chen M; Lu J; Zhang L; Liu Y; Zhao Y; Bao J; Chen W; Luo J; Li X; Chen Z; Cao J
    J Transl Med; 2023 May; 21(1):343. PubMed ID: 37221577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.